Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: analysis from a single oncological center

por Graziosi, L., Marino, E., De Angelis, V., Rebonato, A., Donini, A.
Publicado 2016

97P Is continuing CDK4-6 inhibitor therapy safe during the COVID-19 pandemic? A UK cancer centre experience

por Angelis, V., McFarlane, P., Cunningham, N., Gennatas, S., Johnston, S.R.D., Okines, A., McGrath, S.
Publicado 2021

Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

por Rebonato, A., Graziosi, L., Maiettini, D., Marino, E., De Angelis, V., Brunese, L., Mosca, S., Metro, G., Rossi, M., Orgera, G., Scialpi, M., Donini, A.
Publicado 2017

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

por Gori, S, Colozza, M, Mosconi, A M, Franceschi, E, Basurto, C, Cherubini, R, Sidoni, A, Rulli, A, Bisacci, C, Angelis, V De, Crinò, L, Tonato, M
Publicado 2004

Krankheitsbezogener Wissenserwerb durch strukturierte Patienteninformation bei Rheumatoider Arthritis (StruPI-RA): Erste Ergebnisse der StruPI-RA-Studie in Deutschland

por Schwarze, M., Fieguth, V., Schuch, F., Sandner, P., Edelmann, E., Händel, A., Kettler, M., Hanke, A., Kück, M., Stein, L., Stille, C., Fellner, M., De Angelis, V., Touissant, S., Specker, C.
Publicado 2020